by Busch Center | Dec 15, 2023
At RSNA 2023 in Chicago, Dr. Busch presented on the retrospective analysis of MRI-guided transurethral ultrasound ablation (TULSA) in prostate cancer lesions at the extreme apex. The clinical findings show TULSA is a promising prostate cancer treatment with minimal...
by Busch Center | Feb 25, 2022
Prostate cancer continues to have a negative impact on the duration and quality of life for males and their families. MRI is transforming the pathway of prostate cancer detection, diagnosis, staging, and surveillance, backed by multiple Level 1 studies and robust...
